Heinz Drexel

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Machine Learning

Cardiovascular Disease

Transcatheter Aortic Valve Replacement

Peripheral Artery Disease

Top Venues

European heart journal. Cardiovascular pharmacotherapy

Journal of clinical medicine

International journal of molecular sciences

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Leiherer, Axel Muendlein, Sylvia Mink, Arthur Mader, Christoph H Saely, Andreas Festa, Peter Fraunberger, Heinz Drexel
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence. International journal of molecular sciences 25 (10) (2024)
Andreas Leiherer, Axel Muendlein, Sylvia Mink, Arthur Mader, Christoph H Saely, Andreas Festa, Peter Fraunberger, Heinz Drexel
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence. International journal of molecular sciences 25 (10) (2024)
Johannes B Vogel, Magdalena Ratz, Pascal Elsner, Alexander Vonbank, Thomas Plattner, Christoph H Saely, Andreas Leiherer, Heinz Drexel
Current Practices of Medication Plans in Austrian Patients Undergoing Coronary Angiography: An In-Depth Analysis. Journal of clinical medicine 13 (11) (2024)
Andreas Leiherer, Axel Muendlein, Sylvia Mink, Arthur Mader, Christoph H Saely, Andreas Festa, Peter Fraunberger, Heinz Drexel
Machine Learning Approach to Metabolomic Data Predicts Type 2 Diabetes Mellitus Incidence. International journal of molecular sciences 25 (10) (2024)
Johannes B Vogel, Magdalena Ratz, Pascal Elsner, Alexander Vonbank, Thomas Plattner, Christoph H Saely, Andreas Leiherer, Heinz Drexel
Current Practices of Medication Plans in Austrian Patients Undergoing Coronary Angiography: An In-Depth Analysis. Journal of clinical medicine 13 (11) (2024)
Sylvia Mink, Heinz Drexel, Andreas Leiherer, Janne Cadamuro, Wolfgang Hitzl, Matthias Frick, Patrick Reimann, Christoph H Saely, Peter Fraunberger
Anti-SARS-CoV-2 Antibodies versus Vaccination Status in CAD Patients with COVID-19: A Prospective, Propensity Score-Matched Cohort Study. Vaccines 12 (8) (2024)
Gert Mayer, Dobromir Dobrev, Juan Carlos Kaski, Anne Grete Semb, Vijay Kunadian, Andreas Zirlik, Stefan Agewall, Heinz Drexel
Management of dyslipidaemia in patients with comorbidities-facing the challenge. European heart journal. Cardiovascular pharmacotherapy (2024)
Andreas Leiherer, Axel Muendlein, Christoph H Saely, Kathrin Geiger, Eva-Maria Brandtner, Christine Heinzle, Stella Gaenger, Sylvia Mink, Reijo Laaksonen, Peter Fraunberger, Heinz Drexel
Coronary Event Risk Test (CERT) as a Risk Predictor for the 10-Year Clinical Outcome of Patients with Peripheral Artery Disease. Journal of clinical medicine 12 (19) (2023)
Christoph Ebenbichler, Heinz Drexel, Ursula Hanusch, Hermann Toplak, Nafeesa N Dhalwani, Ian Bridges, Robert Hoelzl, Margit Hemetsberger, Kausik K Ray
Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study. Wiener klinische Wochenschrift (2023)
Heinz Drexel, Christoph H Saely, Stefan Agewall
Fibrates: one more lost paradise in lipid treatment. European heart journal. Cardiovascular pharmacotherapy 9 (2) (2023)
Sylvia Mink, Christoph H Saely, Matthias Frick, Andreas Leiherer, Heinz Drexel, Peter Fraunberger
Association between Lipid Levels, Anti-SARS-CoV-2 Spike Antibodies and COVID-19 Mortality: A Prospective Cohort Study. Journal of clinical medicine 12 (15) (2023)
Luise Adam, Eva Strickler, Meisam K Borozadi, Simone Bein, Arjola Bano, Taulant Muka, Heinz Drexel, Jörn F Dopheide
Prognostic Role of Polyvascular Involvement in Patients with Symptomatic Peripheral Artery Disease. Journal of clinical medicine 12 (10) (2023)
Heinz Drexel, Juan Tamargo, Juan-Carlos Kaski, Basil S Lewis, Christoph H Saely, Peter Fraunberger, Dobromir Dobrev, Maki Komiyama, Thomas Plattner, Stefan Agewall, Koji Hasegawa
Triglycerides Revisited: is Hypertriglyceridaemia a Necessary Therapeutic Target in Cardiovascular Disease? European heart journal. Cardiovascular pharmacotherapy (2023)
Heinz Drexel, Christoph H Saely, Stefan Agewall
Fibrates: One more lost paradise in lipid treatment. European heart journal. Cardiovascular pharmacotherapy (2023)
Christian Hoffmann, Thomas Wechselberger, Heinz Drexel, Susanne Dertinger, Stefan Dirnhofer, Sheila K Pierson, David C Fajgenbaum, Andreas Kessler
Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine. Vaccines 10 (10) (2022)
Jörn F Dopheide, Patrick Gillmann, David Spirk, Meisam Khorrami Borozadi, Luise Adam, Heinz Drexel
False versus True Statin Intolerance in Patients with Peripheral Artery Disease. Journal of clinical medicine 11 (22) (2022)
Alexander Niessner, Heinz Drexel
PCSK9 inhibition in patients with heart failure: neutral or harmful intervention? European heart journal 43 (16) (2022)
Heinz Drexel, Basil S Lewis, Giuseppe M C Rosano, Christoph H Saely, Gerda Tautermann, Kurt Huber, Joern F Dopheide, Juan Carlos Kaski, Arthur Mader, Alexander Niessner, Gianluigi Savarese, Thomas A Schmidt, AnneGrete Semb, Juan Tamargo, Sven Wassmann, Keld Per Kjeldsen, Stefan Agewall, Stuart J Pocock
The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials. European heart journal. Cardiovascular pharmacotherapy 7 (5) (2022)
Juan Tamargo, Juan Carlos Kaski, Takeshi Kimura, Jack Charles Barton, Ko Yamamoto, Maki Komiyama, Heinz Drexel, Basil S Lewis, Stefan Agewall, Koji Hasegawa
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events. European heart journal. Cardiovascular pharmacotherapy 8 (7) (2022)
Heinz Drexel, Stuart J Pocock, Basil S Lewis, Christoph H Saely, Juan Carlos Kaski, Giuseppe M C Rosano, Gerda Tautermann, Kurt Huber, Joern F Dopheide, Arthur Mader, Alexander Niessner, Gianluigi Savarese, Thomas A Schmidt, Anne Grete Semb, Juan Tamargo, Sven Wassmann, Martin Clodi, Keld Per Kjeldsen, Stefan Agewall
Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy (2021)
Andreas Leiherer, Axel Mündlein, Reijo Laaksonen, Mitja Lääperi, Antti Jylhä, Peter Fraunberger, Heinz Drexel
Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients. European journal of preventive cardiology (2021)
Peter Siostrzonek, Helmut Brath, Robert Zweiker, Heinz Drexel, Robert Hoelzl, Margit Hemetsberger, Kausik K Ray
Lipid lowering therapy in primary and secondary prevention in Austria: are LDL-C goals achieved? : Results from the DA VINCI study. Wiener klinische Wochenschrift (2021)
Lukas Sprenger, Arthur Mader, Barbara Larcher, Maximilian Mächler, Alexander Vonbank, Daniela Zanolin-Purin, Andreas Leiherer, Axel Muendlein, Heinz Drexel, Christoph H Saely
Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease. BMJ open diabetes research & care 9 (2) (2021)
Victor Aboyans, Rupert M Bauersachs, Lucia Mazzolai, Marianne Brodmann, José F Rodriguez Palomares, Sebastian Debus, Jean Philippe Collet, Heinz Drexel, Christine Espinola-Klein, Basil S Lewis, Marco Roffi, Dirk Sibbing, Henrik Sillesen, Eugenio Stabile, Oliver Schlager, Marco De Carlo
Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy. European heart journal 42 (39) (2021)
Christoph H Saely, Arthur Mader, Christine F Heinzle, Daniela Zanolin-Purin, Barbara Larcher, Alexander Vonbank, Heinz Drexel
Diabetes Awareness Among Coronary Artery Disease Patients Is Higher in Women Than in Men. Diabetes care 42 (6) (2019)
Heinz Drexel, Andreas Leiherer, Christoph H Saely, Eva Maria Brandtner, Kathrin Geiger, Alexander Vonbank, Peter Fraunberger, Axel Muendlein
Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis. Bioscience reports 39 (8) (2019)